Efficacy, safety and prognostic factors in patients with refractory metastatic colorectal cancer treated with trifluridine/tipiracil plus bevacizumab in a real-world setting

por Martínez-Lago, Nieves, Chucla, Teresa Calleja, De Castro, Beatriz Alonso, Ponte, Rafael Varela, Rendo, Cristina Reboredo, Rodriguez, Martin Igor Gomez-Randulfe, Diaz, Sofia Silva, Suarez, Begoña Graña, de la Cámara Gomez, Juan, Fernández, Fernando Busto, Salvador, María Mateos, Lopez, Margarita Reboredo
Publicado 2022

Efficacy and safety of FOLFIRI/aflibercept in second‐line treatment of metastatic colorectal cancer in a real‐world population: Prognostic and predictive markers

por Fernández Montes, Ana, Martínez Lago, Nieves, Covela Rúa, Marta, de la Cámara Gómez, Juan, González Villaroel, Paula, Méndez Méndez, José Carlos, Jorge Fernández, Mónica, Salgado Fernández, Mercedes, Reboredo López, Margarita, Quintero Aldana, Guillermo, Luz Pellón Augusto, María, Graña Suárez, Begoña, García Gómez, Jesús
Publicado 2019

Prediction of survival in patients with advanced, refractory colorectal cancer in treatment with trifluridine/tipiracil: real-world vs clinical trial data

por Fernández Montes, Ana, Carmona-Bayonas, Alberto, Jimenez-Fonseca, Paula, Vázquez Rivera, Francisca, Martinez Lago, Nieves, Covela Rúa, Marta, Cousillas Castiñeiras, Antía, Gonzalez Villarroel, Paula, De la Cámara Gómez, Juan, Méndez, José Carlos Méndez, Carriles Fernández, Carmen, Sanchez Cánovas, Manuel, Garcia García, Teresa
Publicado 2021

Efficacy and safety of FOLFIRI/aflibercept (FA) in an elderly population with metastatic colorectal cancer (mCRC) after failure of an oxaliplatin-based regimen

por Martínez-Lago, Nieves, Cameselle García, Soledad, Alonso de Castro, Beatriz, Gómez-Randulfe Rodríguez, Martín I., Carmona Campos, Marta, González Villarroel, Paula, Salgado Fernández, Mercedes, De la Cámara Gómez, Juan C., Romero Reinoso, Carlos, Cousillas Castiñeiras, Antía, Méndez Méndez, José Carlos, Vidal Insua, Yolanda, Fernández-Montes, Ana
Publicado 2022

Effect of antiangiogenic-based treatment and systemic inflammatory factors on outcomes in patients with BRAF v600-mutated metastatic colorectal cancer: a real-world study in Spain

por Martínez-Lago, Nieves, Fernández-Montes, Ana, Covela, Marta, Brozos, Elena M., De la Cámara, Juan, Méndez Méndez, José C., Jorge-Fernández, Mónica, Cousillas Castiñeiras, Antía, Reboredo, Cristina, Arias Ron, David, Pellón Augusto, María L., González Villarroel, Paula, Graña, Begoña, Salgado Fernández, Mercedes, Carral Maseda, Alberto, Vázquez Rivera, Francisca, Candamio Folgar, Sonia, Reboredo López, Margarita
Publicado 2021

Do Clinical Trials Meet Current Care Needs? Views of Digestive Oncology Specialists in Galicia (Spain) Using the Delphi Method

por Fernández Montes, Ana, Martinez-Lago, Nieves, de la Cámara Gomez, Juan, Brozos Vázquez, Elena María, Candamio Folgar, Sonia, Carmona Campos, Marta, Cousillas Castiñeiras, Antía, Covela Rúa, Marta, Gallardo Martín, Elena, González Villarroel, Paula, Graña Suarez, Begoña, Jorge Fernández, Mónica, Pellón Augusto, María Luz, Quintero Aldana, Guillermo, Romero Reinoso, Carlos, Salgado Fernández, Mercedes, Vázquez Rivera, Francisca, Ayuso Álvarez, Ana, Culqui, Dante R., Méndez Méndez, José Carlos
Publicado 2021

Second-line treatment in advanced gastric cancer: Data from the Spanish AGAMENON registry

por Cotes Sanchís, Almudena, Gallego, Javier, Hernandez, Raquel, Arrazubi, Virginia, Custodio, Ana, Cano, Juana María, Aguado, Gema, Macias, Ismael, Lopez, Carlos, López, Flora, Visa, Laura, Garrido, Marcelo, Martínez Lago, Nieves, Fernández Montes, Ana, Limón, María Luisa, Azkárate, Aitor, Pimentel, Paola, Reguera, Pablo, Ramchandani, Avinash, Cacho, Juan Diego, Martín Carnicero, Alfonso, Granja, Mónica, Martín Richard, Marta, Hernández Pérez, Carolina, Hurtado, Alicia, Serra, Olbia, Buxo, Elvira, Vidal Tocino, Rosario, Jimenez-Fonseca, Paula, Carmona-Bayonas, Alberto
Publicado 2020

External validity of clinical trials with diverse trastuzumab-based chemotherapy regimens in advanced gastroesophageal adenocarcinoma: data from the AGAMENON-SEOM registry

por Jimenez-Fonseca, Paula, Carmona-Bayonas, Alberto, Martinez-Torron, Alba, Alsina, Maria, Custodio, Ana, Serra, Olbia, Cacho Lavin, Diego, Limón, María Luisa, Sauri, Tamara, López, Flora, Visa, Laura, Granja, Mónica, Martínez Lago, Nieves, Arrazubi, Virginia, Vidal Tocino, Rosario, Hernandez, Raquel, Aguado, Gema, Cano, Juana María, Martín Carnicero, Alfonso, Mangas, Monserrat, Pimentel, Paola, Fernández Montes, Ana, Macias Declara, Ismael, Longo, Federico, Ramchandani, Avinash, Martín Richard, Marta, Hurtado, Alicia, Azkarate, Aitor, Hernández Pérez, Carolina, Serrano, Raquel, Gallego, Javier
Publicado 2021

Do Antiangiogenics Promote Clot Instability? Data from the TESEO Prospective Registry and Caravaggio Clinical Trial

por Carmona-Bayonas, Alberto, Verso, Melina, Sánchez Cánovas, Manuel, Rubio Pérez, Jaime, García de Herreros, Marta, Martínez del Prado, Purificación, Fernández Pérez, Isaura, Quintanar Verduguez, Teresa, Obispo Portero, Berta, Pachón Olmos, Vanessa, Gómez, David, Ortega, Laura, Serrano Moyano, Marta, M. Brozos, Elena, Biosca, Mercedes, Antonio Rebollo, Maite, Teijeira Sanchez, Lucía, Hernández Pérez, Carolina, David Cumplido Burón, José, Martínez Lago, Nieves, García Pérez, Estefanía, Muñoz Langa, Jose, Pérez Segura, Pedro, Martínez de Castro, Eva, Jimenez-Fonseca, Paula, Agnelli, Giancarlo, Muñoz, Andrés
Publicado 2022

External validity of docetaxel triplet trials in advanced gastric cancer: are there patients who still benefit?

por Jimenez-Fonseca, Paula, Carmona-Bayonas, Alberto, Martínez de Castro, Eva, Custodio, Ana, Pericay Pijaume, Carles, Hernandez, Raquel, Aguado, Gema, Castro Unanua, Natalia, Cano, Juana María, López, Flora, Garrido, Marcelo, Fernández Montes, Ana, Visa, Laura, Sánchez Cánovas, Manuel, Limón, María Luisa, Martínez Lago, Nieves, Pimentel, Paola, Hurtado, Alicia, Azkárate, Aitor, Longo, Federico, Diez, Marc, Arias-Martinez, Aranzazu, Sauri, Tamara, Martín Carnicero, Alfonso, Mangas, Monserrat, Martín Richard, Marta, Granja, Mónica, Ramchandani, Avinash, Hernández Pérez, Carolina, Cerdá, Paula, Gil-Negrete, Aitziber, Calvo, Mariona, Vidal Tocino, Rosario, Gallego, Javier
Publicado 2020

The AGAMENON-SEOM model for prediction of survival in patients with advanced HER2-positive oesophagogastric adenocarcinoma receiving first-line trastuzumab-based therapy

por Jimenez-Fonseca, Paula, Foy, Victoria, Raby, Sophie, Carmona-Bayonas, Alberto, Macía-Rivas, Lola, Arrazubi, Virginia, Cacho Lavin, Diego, Hernandez San Gil, Raquel, Custodio, Ana, Cano, Juana María, Fernández Montes, Ana, Mirallas, Oriol, Macias Declara, Ismael, Vidal Tocino, Rosario, Visa, Laura, Limón, María Luisa, Pimentel, Paola, Martínez Lago, Nieves, Sauri, Tamara, Martín Richard, Marta, Mangas, Monserrat, Gil Raga, Mireia, Calvo, Aitana, Reguera, Pablo, Granja, Mónica, Martín Carnicero, Alfonso, Hernández Pérez, Carolina, Cerdá, Paula, Gomez Gonzalez, Lucía, Garcia Navalon, Francisco, Pacheco Barcia, Vilma, Gutierrez Abad, David, Ruiz Martín, Maribel, Weaver, Jamie, Mansoor, Wasat, Gallego, Javier
Publicado 2023